WallStreetZenWallStreetZen

NASDAQ: CRNX
Crinetics Pharmaceuticals Inc Stock Ownership - Who owns Crinetics Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crinetics Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dana PizzutiChief Med and Dev Officer2025-12-015,000$45.02
$225.10kSell
Dana PizzutiChief Med and Dev Officer2025-12-015,000$16.89
$84.45kBuy
Dana PizzutiChief Med and Dev Officer2025-11-034,900$42.65
$208.99kSell
Dana PizzutiChief Med and Dev Officer2025-11-03100$43.27
$4.33kSell
Dana PizzutiChief Med and Dev Officer2025-11-035,000$16.89
$84.45kBuy
Dana PizzutiChief Med and Dev Officer2025-10-015,000$41.81
$209.05kSell
Dana PizzutiChief Med and Dev Officer2025-10-015,000$16.89
$84.45kBuy
Matthew K. FustDirector2025-09-2610,000$1.91
$19.10kBuy
Richard Scott StruthersPresident CEO2025-09-264,000$45.00
$180.00kSell
Matthew K. FustDirector2025-09-2616,000$44.75
$716.00kSell

1 of 4

CRNX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRNX insiders and whales buy or sell their stock.

CRNX Shareholders

What type of owners hold Crinetics Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.95%14,187,498$716.33MInstitution
Vanguard Group Inc9.66%9,170,129$463.00MInstitution
Wellington Management Group LLP8.83%8,381,991$423.21MInstitution
Perceptive Advisors LLC8.33%7,908,985$399.32MInsider
Blackrock Inc7.99%7,586,597$383.05MInstitution
Driehaus Capital Management LLC6.83%6,481,613$327.26MInstitution
Farallon Capital Management LLC6.08%5,770,098$291.33MInstitution
Price T Rowe Associates Inc5.59%5,306,248$267.91MInstitution
Ecor1 Capital LLC4.52%4,288,120$216.51MInstitution
Janus Henderson Group PLC4.07%3,858,791$194.83MInstitution

1 of 3

CRNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRNX89.37%10.63%Net BuyingNet Selling
SRRK62.40%37.60%Net BuyingNet Buying
CELC76.71%23.29%Net BuyingNet Selling
ADMA79.67%20.33%Net SellingNet Selling
IMVT44.51%55.49%Net BuyingNet Buying
View Top Biotech Stocks

Crinetics Pharmaceuticals Stock Ownership FAQ

Who owns Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals (NASDAQ: CRNX) is owned by 113.50% institutional shareholders, 13.49% Crinetics Pharmaceuticals insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Crinetics Pharmaceuticals shareholder, owning 7.91M shares representing 8.33% of the company. Perceptive Advisors LLC's Crinetics Pharmaceuticals shares are currently valued at $399.32M.

If you're new to stock investing, here's how to buy Crinetics Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.